Friday, May 25, 2012
Catalyst Pharmaceutical Partners Inc., of Coral Gables, Fla., said it priced a public offering of 6 million units each unit comprising one share of common stock and a warrant to purchase up to one share at 80 cents apiece.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.